Transcriptional analysis of hnRNPA0, A1, A2, B1, and A3 in lung cancer cell lines in response to acidosis, hypoxia, and serum deprivation conditions

REFERENCES

• Han SP, Tang YH, Smith R: Functional diversity of the hnRNPs: past, present and perspectives. Biochem J. 2010; 430(3):379–392.
   PubMedGoogle Scholar
• Ma AS, Moran-Jones K, Shan J, Munro TP, Snee MJ, Hoek KS, Smith R: Heterogeneous nuclear ribonucleoprotein A3, a novel RNA trafficking response element-binding protein. J Biol Chem. 2002;277(20):18010–18020.
   PubMed Web of Science ®Google Scholar
• Myer VE, Steitz JA: Isolation and characterization of a novel, low abundance hnRNP protein: A0. RNA. 1995;1(2):171–182.
   PubMed Web of Science ®Google Scholar
• Kamma H, Horiguchi H, Wan L, Matsui M, Fujiwara M, Fujimoto M, Yazawa T, Dreyfuss G: Molecular characterization of the hnRNP A2/B1 proteins: tissue-specific expression and novel isoforms. Exp Cell Res. 1999;246(2):399–411.
   PubMed Web of Science ®Google Scholar
• Han SP, Kassahn KS, Skarshewski A, Ragan MA, Rothnagel JA, Smith R: Functional implications of the emergence of alternative splicing in hnRNP A/B transcripts. RNA. 2010;16(9):1760–1768.
   PubMed Web of Science ®Google Scholar
• He Y, Brown MA, Rothnagel JA, Saunders NA, Smith R: Roles of heterogeneous nuclear ribonucleoproteins A and B in cell proliferation. J Cell Sci. 2005;118(Pt 14):3173–3183.
   PubMed Web of Science ®Google Scholar
• He Y, Smith R: Nuclear functions of heterogeneous nuclear ribonucleoproteins A/B. Cell Mol Life Sci. 2009;66(7): 1239–1256.
   PubMed Web of Science ®Google Scholar
• McGlincy NJ, Tan LY, Paul N, Zavolan M, Lilley KS, Smith CW: Expression proteomics of UPF1 knockdown in HeLa cells reveals autoregulation of hnRNP A2/B1 mediated by alternative splicing resulting in nonsense-mediated mRNA decay. BMC Genom. 2010;11:565.
   PubMed Web of Science ®Google Scholar
• David CJ, Manley JL: Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev. 2010;24(21):2343–2364.
   PubMed Web of Science ®Google Scholar
• Choi HS, Lee HM, Jang YJ, Kim CH, Ryu CJ: Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the selfrenewal and pluripotency of human embryonic stem cells via the control of the G1/S transition. Stem Cells. 2013. doi: 10.1002 /stem.1366.
   Web of Science ®Google Scholar
• Zhu D, Xu G, Ghandhi S, Hubbard K: Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: implications for cellular senescence. J Cell Physiol. 2002;193(1):19–25.
   PubMed Web of Science ®Google Scholar
• Oh HK, Lee E, Jang HN, Lee J, Moon H, Sheng Z, Jun Y, Loh TJ, Cho S, Zhou J, Green MR, Zheng X, Shen H: hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene. Apoptosis. 2013;18(7):825–835.
   PubMed Web of Science ®Google Scholar
• Choi YH, Lim JK, Jeong MW, Kim KT: HnRNP A1 phosphorylated by VRK1 stimulates telomerase and its binding to telomeric DNA sequence. Nucleic Acids Res. 2012;40(17):8499–8518.
   PubMed Web of Science ®Google Scholar
• Zhou ZJ, Dai Z, Zhou SL, Fu XT, Zhao YM, Shi YH, Zhou J, Fan J: Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma. Int J Cancer. 2012;132(5):1080–1089.
   PubMed Web of Science ®Google Scholar
• Ma YL, Peng JY, Zhang P, Huang L, Liu WJ, Shen TY, Chen HQ, Zhou YK, Zhang M, Chu ZX, Qin HL: Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology. J Proteome Res. 2009;8(10):4525–4535.
   PubMed Web of Science ®Google Scholar
• Wu S, Sato M, Endo C, Sakurada A, Dong B, Aikawa H, Chen Y, Okada Y, Matsumura Y, Sueoka E, Kondo T: hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung. Lung Cancer. 2003;41(2):179–186.
   PubMed Web of Science ®Google Scholar
• Cui H, Wu F, Sun Y, Fan G, Wang Q: Up-regulation and subcellular localization of hnRNP A2/B1 in the development of hepatocellular carcinoma. BMC Cancer. 2010;10:356.
   PubMed Web of Science ®Google Scholar
• Mizuno H, Honda M, Shirasaki T, Yamashita T, Yamashita T, Mizukoshi E, Kaneko S: Heterogeneous nuclear ribonucleoprotein A2/B1 in association with hTERT is a potential biomarker for hepatocellular carcinoma. Liver Int. 2012;32(7):1146–1155.
   PubMed Web of Science ®Google Scholar
• Jing GJ, Xu DH, Shi SL, Li QF, Wang SY, Wu FY, Kong HY: Aberrant expression and localization of hnRNP-A2/B1 is a common event in human gastric adenocarcinoma. J Gastroenterol Hepatol. 2011;26(1):108–115.
   PubMed Web of Science ®Google Scholar
• Sueoka E, Sueoka N, Iwanaga K, Sato A, Suga K, Hayashi S, Nagasawa K, Nakachi K: Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction. Lung Cancer. 2005;48(1):77–83.
   PubMed Web of Science ®Google Scholar
• Moran-Jones K, Grindlay J, Jones M, Smith R, Norman JC: hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration. Cancer Res. 2009;69(24):9219–9227.
   PubMed Web of Science ®Google Scholar
• Clower CV, Chatterjee D, Wang Z, Cantley LC, Vander Heiden MG, Krainer AR: The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. Proc Natl Acad Sci USA. 2010;107(5):1894–1899.
   PubMed Web of Science ®Google Scholar
• David CJ, Chen M, Assanah M, Canoll P, Manley JL: HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature. 2010;463(7279):364–368.
   PubMed Web of Science ®Google Scholar
• Romero-Garcia S, Lopez-Gonzalez JS, Báez-Viveros JL, Aguilar-Cazares D, Prado-Garcia H: Tumor cell metabolism: an integral view. Cancer Biol Ther. 2011;12(11):939–948.
   PubMed Web of Science ®Google Scholar
• Garayoa M, Man YG, Martínez A, Cuttitta F, Mulshine JL: Downregulation of hnRNP A2/B1 expression in tumor cells under prolonged hypoxia. Am J Respir Cell Mol Biol. 2003;28(1):80–85.
   PubMed Web of Science ®Google Scholar
• Lopez-Gonzalez JS, Prado-Garcia H, Aguilar-Cazares D, Molina-Guarneros JA, Morales-Fuentes J, Mandoki JJ: Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer. 2004;43(3):275–283.
   PubMed Web of Science ®Google Scholar
• Mane VP, Heuer MA, Hillyer P, Navarro MB, Rabin RL: Systematic method for determining an ideal housekeeping gene for real-time PCR analysis. J Biomol Tech. 2008;19(5): 342–347.
   PubMedGoogle Scholar
• Soria S, de Anda R, Flores N, Romero-Garcia S, Gosset G, Bolívar F, Báez-Viveros JL: New insights on transcriptional responses of genes involved in carbon central metabolism, respiration and fermentation to low ATP levels in Escherichia coli. J Basic Microbiol. 2013;53(4):365–380.
   PubMed Web of Science ®Google Scholar
• Kozu T, Henrich B, Schäfer KP.: Structure and expression of the gene (HNRPA2B1) encoding the human hnRNP protein A2/B1. Genomics. 1995;25(2):365–371.
   PubMed Web of Science ®Google Scholar
• Pino I, Pío R, Toledo G, Zabalegui N, Vicent S, Rey N, Lozano MD, Torre W, García-Foncillas J, Montuenga LM: Altered patterns of expression of members of the heterogeneous nuclear ribonucleoprotein (hnRNP) family in lung cancer. Lung Cancer. 2003;41(2):131–143.
   PubMed Web of Science ®Google Scholar
• Boukakis G, Patrinou-Georgoula M, Lekarakou M, Valavanis C, Guialis A: Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues. BMC Cancer. 2010;10:434.
   PubMed Web of Science ®Google Scholar
• Guha M, Pan H, Fang JK, Avadhani NG: Heterogeneous nuclear ribonucleoprotein A2 is a common transcriptional coactivator in the nuclear transcription response to mitochondrial respiratory stress. Mol Biol Cell. 2009;20(18): 4107–4119.
   PubMed Web of Science ®Google Scholar
• Golan-Gerstl R, Cohen M, Shilo A, Suh SS, Bakàcs A, Coppola L, Karni R: Splicing factor hnRNP A2/B1 regulates tumor suppressor gene splicing and is an oncogenic driver in glioblastoma. Cancer Res. 2011;71(13):4464–4472.
   PubMed Web of Science ®Google Scholar
• Tauler J, Zudaire E, Liu H, Shih J, Mulshine JL: hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines. Cancer Res. 2010;70(18):7137–7147.
   PubMed Web of Science ®Google Scholar
• Ye Q, Kantonen S, Gomez-Cambronero J: Serum deprivation confers the MDA-MB-231 breast cancer line with an EGFR/JAK3/PLD2 system that maximizes cancer cell invasion. J Mol Biol. 2013;425(4):755–766.
   PubMed Web of Science ®Google Scholar